EUVIMEDEUVIMED entdecken
Crossref

Potentials and Challenges of Unmanned Aerial Vehicle–Based Transport for the Time-Critical Delivery of Positron Emission Tomography Radiopharmaceuticals in Nuclear Medicine

Olga Varlamova iD, Jan Bredow, Matthias Nattke iD, Winfried Brenner, Katharina Frentzel, Michael Starke

Nuklearmedizin - NuclearMedicine · 15.10.2026

DOI: 10.1055/a-2966-8652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 15.10.2026. Verfasst von Olga Varlamova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Universität Lausitz - Carl Thiem, Department of Nuclear Medicine, BB, Germany, Cottbus. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Positron emission tomography radiopharmaceuticals have short physical half-lives, making transport time a key determinant of their clinical availability. This study evaluated the potential of unmanned aerial vehicle–based transport to improve radiopharmaceutical distribution compared with conventional road transport. Ground- and unmanned aerial vehicle–based transport scenarios were compared within standardized regulatory and radiopharmacy frameworks. Representative distribution routes were analysed, and radioactive decay was modelled using exponential decay kinetics. Activity preservation was evaluated for 18F, 68Ga, and 11C using representative distribution scenarios for 18F-FDG and 68Ga-PSMA. The modelling analysis predicted shorter and more predictable delivery times for unmanned aerial vehicle–based transport than for conventional road transport. The reduced transport duration increased the residual activity available at the time of administration, with the greatest benefit predicted for short-lived radionuclides. In a representative scenario, reducing the transport time from approximately 110 to 70 minutes was associated with increased residual 18F activity from approximately 50 to 64%. A corresponding increase from approximately 33 to 49% was predicted for 68Ga, whereas 11C exhibited the greatest sensitivity to transport time. Unmanned aerial vehicle–based transport could improve positron emission tomography radiopharmaceutical distribution by reducing decay losses, increasing operational flexibility, and enabling higher patient throughput per production batch. Clinical implementation remains limited by regulatory, technical, and environmental challenges. Experimental validation and real-world studies are needed to confirm feasibility.

Autor:innen und Institutionen

  • Medizinische Universität Lausitz - Carl Thiem, Department of Nuclear Medicine, BB, Germany, Cottbus.
  • Brandenburg University of Technology Cottbus-Senftenberg, Institute of Computer Science and Information and Media Technology, BB, Germany, Cottbus.
  • Charite - Universitätsmedizin Berlin, Department of Nuclear Medicine, BE, Germany, Berlin.
  • Klinikum Ernst von Bergmann gGmbH, Department of Nuclear Medicine, BB, Germany, Potsdam.

ORCID-Profile: Olga Varlamova, Matthias Nattke

Zitieren

APA

Varlamova, O., Bredow, J., Nattke, M., Brenner, W., Frentzel, K., & Starke, M. (2026). Potentials and Challenges of Unmanned Aerial Vehicle–Based Transport for the Time-Critical Delivery of Positron Emission Tomography Radiopharmaceuticals in Nuclear Medicine. Nuklearmedizin - NuclearMedicine. https://doi.org/10.1055/a-2966-8652

Vancouver

Varlamova O, Bredow J, Nattke M, Brenner W, Frentzel K, Starke M. Potentials and Challenges of Unmanned Aerial Vehicle–Based Transport for the Time-Critical Delivery of Positron Emission Tomography Radiopharmaceuticals in Nuclear Medicine. Nuklearmedizin - NuclearMedicine. 2026. doi:10.1055/a-2966-8652

BibTeX
@article{Varlamova2026,
  author = {Varlamova, Olga and Bredow, Jan and Nattke, Matthias and Brenner, Winfried and Frentzel, Katharina and Starke, Michael},
  title = {Potentials and Challenges of Unmanned Aerial Vehicle–Based Transport for the Time-Critical Delivery of Positron Emission Tomography Radiopharmaceuticals in Nuclear Medicine},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2026},
  doi = {10.1055/a-2966-8652}
}
Kostenlos starten →